Spots Global Cancer Trial Database for The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
Official Title: A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma
Study ID: NCT00002366
Interventions
Study Description
Brief Summary: To evaluate the safety and anti-Kaposi's sarcoma activity of ritonavir.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Prince Henry's Hosp / Med Oncology, Sydney, , Australia
Saint Vincent's Hosp Med Centre, Sydney, , Australia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
